New cell therapy aims to free kidney transplant patients from insulin dependence
NCT ID NCT06832410
Summary
This study is testing an investigational cell therapy called VX-880 in people who have type 1 diabetes and have already received a kidney transplant. The main goal is to see if the treatment can help participants stop needing insulin injections. Participants must already be on stable anti-rejection medications for their kidney transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology
RECRUITINGRiyadh, Saudi Arabia
-
King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology
RECRUITINGRiyadh, Saudi Arabia
-
Montefiore Clinical and Translational Research Center - Endocrinology
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
Perelman Center for Advanced Medicine - Endocrinology
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Toronto General Hospital - Endocrinology
RECRUITINGToronto, Canada
-
UW University Hospital - Endocrinology
RECRUITINGMadison, Wisconsin, 53792, United States
-
Vancouver General Hospital - Gordon and Leslie Diamond Health Care Centre
RECRUITINGVancouver, Canada
Conditions
Explore the condition pages connected to this study.